Are orthodontic randomised controlled trials justified with a citation of an appropriate systematic review?

CONSORT Interventional studies Orthodontics Research waste SPIRIT Systematic reviews

Journal

Progress in orthodontics
ISSN: 2196-1042
Titre abrégé: Prog Orthod
Pays: Germany
ID NLM: 100936353

Informations de publication

Date de publication:
17 Dec 2021
Historique:
received: 29 09 2021
accepted: 06 12 2021
entrez: 17 12 2021
pubmed: 18 12 2021
medline: 21 12 2021
Statut: epublish

Résumé

A systematic review of the evidence should be undertaken to support the justification for undertaking a clinical trial. The aim of this study was to examine whether reports of orthodontic Randomised Clinical Trials (RCTs) cite prior systematic reviews (SR) to explain the rationale or justification of the trial. Study characteristics that predicated the citation of SR in the RCT report were also explored. Orthodontic RCTs published between 1st January 2010 to 31st December 2020 in seven orthodontic journals were identified. All titles and abstracts were screened independently by two authors. Descriptive statistics and associations were assessed for the study characteristics. Logistic regression was used to identify predicators of SR inclusion in the trial report. 301 RCTs fulfilling the eligibility criteria were assessed. 220 SRs were available of which 74.5% (N = 164) were cited, and 24.5% (N = 56) were not included but were available in the literature within 12 months of trial commencement. When a SR was not included in the introduction or no SR was available within 12 months of trial commencement, interventional studies were commonly cited. The continent of the corresponding author predicated the possibility of inclusion of a SR in the introduction (OR 0.36; 95% CI 0.18-0.71; p = 0.003). A quarter of orthodontic RCTs (24.5%) included in this study did not cite a SR in the introduction section to justify the rationale of the trial when a relevant SR was available. To reduce research waste and optimal usage of resources, researchers should identify or conduct a systematic review of the evidence to support the rationale and justification of the trial.

Sections du résumé

BACKGROUND BACKGROUND
A systematic review of the evidence should be undertaken to support the justification for undertaking a clinical trial. The aim of this study was to examine whether reports of orthodontic Randomised Clinical Trials (RCTs) cite prior systematic reviews (SR) to explain the rationale or justification of the trial. Study characteristics that predicated the citation of SR in the RCT report were also explored.
MATERIAL AND METHODS METHODS
Orthodontic RCTs published between 1st January 2010 to 31st December 2020 in seven orthodontic journals were identified. All titles and abstracts were screened independently by two authors. Descriptive statistics and associations were assessed for the study characteristics. Logistic regression was used to identify predicators of SR inclusion in the trial report.
RESULTS RESULTS
301 RCTs fulfilling the eligibility criteria were assessed. 220 SRs were available of which 74.5% (N = 164) were cited, and 24.5% (N = 56) were not included but were available in the literature within 12 months of trial commencement. When a SR was not included in the introduction or no SR was available within 12 months of trial commencement, interventional studies were commonly cited. The continent of the corresponding author predicated the possibility of inclusion of a SR in the introduction (OR 0.36; 95% CI 0.18-0.71; p = 0.003).
CONCLUSIONS CONCLUSIONS
A quarter of orthodontic RCTs (24.5%) included in this study did not cite a SR in the introduction section to justify the rationale of the trial when a relevant SR was available. To reduce research waste and optimal usage of resources, researchers should identify or conduct a systematic review of the evidence to support the rationale and justification of the trial.

Identifiants

pubmed: 34918200
doi: 10.1186/s40510-021-00395-z
pii: 10.1186/s40510-021-00395-z
pmc: PMC8677858
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

48

Informations de copyright

© 2021. The Author(s).

Références

Lancet. 2014 Jan 18;383(9913):267-76
pubmed: 24411647
J Clin Epidemiol. 2014 Sep;67(9):1044-8
pubmed: 24837296
J Am Dent Assoc. 2015 Sep;146(9):669-678.e1
pubmed: 26314976
J Dent. 2021 Jun;109:103658
pubmed: 33836249
JAMA. 1998 Jul 15;280(3):280-2
pubmed: 9676682
J Clin Epidemiol. 2018 May;97:20-25
pubmed: 29306063
Lancet. 2009 Jul 4;374(9683):86-9
pubmed: 19525005
Trials. 2018 Feb 17;19(1):116
pubmed: 29454390
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
BMJ. 2004 Dec 11;329(7479):1360
pubmed: 15591544
J Evid Based Med. 2020 Aug;13(3):181-182
pubmed: 32615030
J Clin Epidemiol. 2010 Aug;63(8):834-40
pubmed: 20346629
Trials. 2016 Dec 7;17(1):581
pubmed: 27927219
BMC Med Res Methodol. 2013 Mar 25;13:50
pubmed: 23530582
Trials. 2014 Jul 16;15:286
pubmed: 25027292
BMC Med Ethics. 2020 Oct 28;21(1):107
pubmed: 33115456
Lancet. 2010 Jul 3;376(9734):20-1
pubmed: 20609983
J R Soc Med. 2007 Apr;100(4):187-90
pubmed: 17404342

Auteurs

Kishan Patel (K)

Department of Orthodontics, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, Kings College Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS, UK.

Martyn T Cobourne (MT)

Centre for Craniofacial Development and Regeneration, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, Guy's Hospital, Guy's and St Thomas NHS Foundation Trust, London, SE1 9RT, UK.

Nikolaos Pandis (N)

Department of Orthodontics and Dentofacial Orthopedics, Dental School/Medical Faculty, University of Bern, Bern, Switzerland.

Jadbinder Seehra (J)

Centre for Craniofacial Development and Regeneration, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, Guy's Hospital, Guy's and St Thomas NHS Foundation Trust, London, SE1 9RT, UK. jadbinderpal.seehra@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH